Boston University researchers have developed an AI model that can predict with 78.5% accuracy whether a person with mild cognitive impairment will develop Alzheimer’s disease within six years. This model analyzes patient speech and could revolutionize early detection and treatment options.
By analyzing speech patterns, a new AI model can say with a high degree of BU-led Framingham Heart Study. Although the Framingham study is focused on cardiovascular health, participants showing signs of cognitive decline undergo regular neuropsychological tests and interviews, producing a wealth of longitudinal information on their cognitive well-being.
Paschalidis and his colleagues were given audio recordings of 166 initial interviews with people, between ages 63 and 97, diagnosed with mild cognitive impairment—76 who would remain stable for the next six years and 90 whose cognitive function would progressively decline. They then used a combination of speech recognition tools—similar to the programs powering your smart speaker—and machine learning to train a model to spot connections between speech, demographics, diagnosis, and disease progression. After training it on a subset of the study population, they tested its predictive prowess on the rest of the participants.
“We combine the information we extract from the audio recordings with some very basic demographics—age, gender, and so on—and we get the final score,” says Paschalidis. “You can think of the score as the likelihood, the probability, that someone will remain stable or transition to dementia. It had significant predictive ability.”
AI: A Tool for Broadening Healthcare Access
Rather than using acoustic features of speech, like enunciation or speed, the model is just pulling from the content of the interview—the words spoken, how they’re structured. And Paschalidis says the information they put into the machine learning program is rough around the edges: the recordings, for example, are messy—low-quality and filled with background noise. “It’s a very casual recording,” he says. “And still, with this dirty data, the model is able to make something out of it.”
That’s important, because the project was partly about testing AI’s ability to make the process of dementia diagnosis more efficient and automated, with little human involvement. In the future, the researchers say, models like theirs could be used to bring care to patients who aren’t near medical centers or to provide routine monitoring through interaction with an at-home app, drastically increasing the number of people who get screened. According to Alzheimer’s Disease International, the majority of people with dementia worldwide never receive a formal diagnosis, leaving them shut off from treatment and care.
Rhoda Au, a coauthor on the paper, says AI has the power to create “equal opportunity science and healthcare.” The study builds on the same team’s previous work, where they found AI could accurately detect cognitive impairment using voice recordings.
“Technology can overcome the bias of work that can only be done by those with resources, or care that has relied on specialized expertise that is not available to everyone,” says Au, a BU Chobanian & Avedisian School of Medicine professor of anatomy and neurobiology. For her, one of the most exciting findings was “that a method for cognitive assessment that has the potential to be maximally inclusive—possibly independent of age, sex/gender, education, language, culture, income, geography—could serve as a potential screening tool for detecting and monitoring symptoms related to Alzheimer’s disease.”
A Dementia Diagnosis From Home
In future research, Paschalidis would like to explore using data not just from formal clinician-patient interviews—with their scripted questions and predictable back-and-forth—but also from more natural, everyday conversations. He’s already looking ahead to a project on if AI can help diagnose dementia via a smartphone app, as well as expanding the current study beyond speech analysis—the Framingham tests also include patient drawings and data on daily life patterns—to boost the model’s predictive accuracy.
“Digital is the new blood,” says Au. “You can collect it, analyze it for what is known today, store it, and reanalyze it for whatever new emerges tomorrow.”
Reference: “Prediction of Alzheimer’s disease progression within 6 years using speech: a novel approach leveraging language models” 25 June 2024, Alzheimer’s & Dementia.
DOI: 10.1002/alz.13886
This research was funded, in part, by the National Science Foundation, the



















Discussion about this post